Mirati Therapeutics, Inc.

ROYAL BANK OF CANADA

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

22,831

Value ($000)

1,342

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	1,342	0.0%	22,831	12/31/2023
2023 Q3	11/14/2023	2,625	0.0%	60,264	9/30/2023
2023 Q2	8/14/2023	1,711	0.0%	47,354	6/30/2023
2023 Q1	5/15/2023	1,850	0.0%	49,762	3/31/2023
2022 Q4	2/14/2023	1,420	0.0%	31,352	12/31/2022
2022 Q3	11/14/2022	1,850	0.0%	26,511	9/30/2022
2022 Q2	8/15/2022	1,629	0.0%	24,273	6/30/2022
2022 Q1	5/16/2022	1,097	0.0%	13,353	3/31/2022
2021 Q4	2/14/2022	8,616	0.0%	58,745	12/31/2021
2021 Q3	11/15/2021	1,655	0.0%	9,355	9/30/2021
2021 Q2	8/16/2021	3,565	0.0%	22,067	6/30/2021
2021 Q1	7/20/2021	7,752	0.0%	45,259	3/31/2021
2020 Q4	2/16/2021	7,453	0.0%	33,934	12/31/2020
2020 Q3	11/16/2020	5,482	0.0%	33,012	9/30/2020
2020 Q2	8/14/2020	5,022	0.0%	43,990	6/30/2020
2020 Q1	6/16/2020	3,030	0.0%	39,412	3/31/2020
2019 Q4	2/14/2020	698	0.0%	5,418	12/31/2019
2014 Q1	5/15/2014	189	0.0%	9,902	3/31/2014
2013 Q4	2/14/2014	411	0.0%	24,723	12/31/2013